Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
With significant or rapid weight loss, particularly when driven by GLP-1 drugs, several mechanisms converge: Loss of underlying fat volume removes structural support Collagen and elastin fibres become stretched and fragmented Speed of weight loss outpaces skin contraction While some rebound occurs naturally, significant laxity can be permanent, especially after large weight reductions
A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE/ mouse model
Sources BUM-CHUN L
Wegovy is indicated for lowering body weight in obese and overweight patients with at least one weight-related disease and treating metabolic dysfunction-associated steatohepatitis (MASH) in patients with mild to moderate liver fibrosis
